Cargando…

Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with worsened outcomes in COVID-19 (coronavirus disease 2019). However, data remain fraught with heterogeneity and bias from comorbid conditions. Additionally, data on the impact of COPD-specific factors, such as pre-hospital med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toppen, William, Yan, Peter, Markovic, Daniela, Shover, Carolyn M, Buhr, Russell G, Fulcher, Jennifer A, Tashkin, Donald P, Barjaktarevic, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788836/ https://www.ncbi.nlm.nih.gov/pubmed/36570857 http://dx.doi.org/10.2147/COPD.S386463

Ejemplares similares

Eosinophil Recovery in Hospitalized COVID-19 Patients is Associated with Lower Rates of ICU Admission and In-Hospital Mortality: An Observational Cohort Analysis
por: Yan, Peter D., et al.
Publicado: (2023)

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis
por: Shover, Carolyn M., et al.
Publicado: (2022)

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023)

Outcomes and Prognostic Factors of Pulmonary Hypertension Patients Undergoing Emergent Endotracheal Intubation
por: Hong, Andrew W., et al.
Publicado: (2022)

How Differential Are the Effects of Smoking Cannabis versus Tobacco on Lung Function?
por: Tashkin, Donald P., et al.
Publicado: (2022)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
por: Tashkin, Donald P
Publicado: (2020)

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
por: Park, Seon-Cheol, et al.
Publicado: (2022)

Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD
por: Park, Seon Cheol, et al.
Publicado: (2023)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

The use of nebulized pharmacotherapies during the COVID-19 pandemic
por: Sethi, Sanjay, et al.
Publicado: (2020)

Defining Disease Modification in Chronic Obstructive Pulmonary Disease
por: Halpin, David M.G., et al.
Publicado: (2009)

Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later Life
por: Tashkin, Donald P.
Publicado: (2023)

Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
por: Tashkin, Donald P, et al.
Publicado: (2010)

The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Park, Hye Yun, et al.
Publicado: (2013)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
por: Tashkin, Donald P, et al.
Publicado: (2020)

Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Suriyakul, Apisara, et al.
Publicado: (2022)

Yet Another Crack in the Facade of the Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program for Chronic Obstructive Pulmonary Disease
por: Buhr, Russell G., et al.
Publicado: (2022)

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
por: Tashkin, Donald P., et al.
Publicado: (2019)

Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study
por: Cosentino, Eugenio Roberto, et al.
Publicado: (2019)

An observational cohort study of exercise and education for people with chronic obstructive pulmonary disease not meeting criteria for formal pulmonary rehabilitation programmes
por: Lewis, A, et al.
Publicado: (2019)

Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)
por: Anzueto, Antonio, et al.
Publicado: (2023)

Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study
por: Park, Seon Cheol, et al.
Publicado: (2019)

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease: Results from a 1-Year Randomized Controlled Clinical Trial
por: Rennard, Stephen I., et al.
Publicado: (2012)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices
por: Buhr, Russell G., et al.
Publicado: (2019)

Age-Period-Cohort Analysis of Chronic Obstructive Pulmonary Disease Mortality in Japan, 1950–2004
por: Pham, Truong-Minh, et al.
Publicado: (2012)

Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort
por: Jacobs, David M, et al.
Publicado: (2020)

Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease
por: Halpern, Michael T, et al.
Publicado: (2006)

Obstructive sleep apnea, chronic obstructive pulmonary disease and hypertensive microvascular disease: a cross-sectional observational cohort study
por: Chew, Sky, et al.
Publicado: (2022)

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease
por: Li, Xuan, et al.
Publicado: (2017)

Air pollution and mortality in patients with chronic obstructive pulmonary disease: a cohort study in South Korea
por: Kang, Suna, et al.
Publicado: (2023)

Associations of total and type-specific physical activity with mortality in chronic obstructive pulmonary disease: a population-based cohort study
por: Cheng, Sonia Wing Mei, et al.
Publicado: (2018)

Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease
por: Cheng, Yan, et al.
Publicado: (2014)

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease
por: Santibáñez, Miguel, et al.
Publicado: (2016)

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study
por: Nakayama, Shingo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_arn4e3c3vcgaeg4f80t3fkp4ck